MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
23
Beneficiaries
—
Total drug cost
$668
Distinct drugs
2
Brand share
47.8%
Top prescribed drugs
Hydroxychloroquine Sulfate12 claims
Methotrexate Sodium11 claims
QUALITY · MIPS · 2024
Final MIPS score
90.5
Quality
68.6
Cost
86.3
Improvement activities
40.0
Promoting interop.
91.0
Payment adjustment
0.65%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE